These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36813801)

  • 1. ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    Nat Commun; 2023 Feb; 14(1):993. PubMed ID: 36813801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    ArXiv; 2021 Sep; ():. PubMed ID: 34545335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases.
    Wen Q; Liu R; Zhang P
    BMC Med Inform Decis Mak; 2021 Sep; 21(Suppl 8):263. PubMed ID: 34560862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases.
    Walpole IR; Zaman FY; Zhao P; Marshall VM; Lin FP; Thomas DM; Shackleton M; Antolin AA; Ameratunga M
    Clin Transl Med; 2024 Apr; 14(4):e1657. PubMed ID: 38629623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine.
    Saha Detroja T; Detroja R; Mukherjee S; Samson AO
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing drugs to treat cardiovascular disease in the era of precision medicine.
    Abdelsayed M; Kort EJ; Jovinge S; Mercola M
    Nat Rev Cardiol; 2022 Nov; 19(11):751-764. PubMed ID: 35606425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. scDrug: From single-cell RNA-seq to drug response prediction.
    Hsieh CY; Wen JH; Lin SM; Tseng TY; Huang JH; Huang HC; Juan HF
    Comput Struct Biotechnol J; 2023; 21():150-157. PubMed ID: 36544472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Sensitivity and Drug Repurposing Platform for Cancer Precision Medicine.
    Nweke EE; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2021; 1326():47-53. PubMed ID: 33629259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of repurposed protein kinase B binders from FDA-approved drug library: a hybrid-structure activity relationship and systems modeling based approach.
    Prakash O; Nath Dwivedi U
    J Biomol Struct Dyn; 2020 Feb; 38(3):660-672. PubMed ID: 30806166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing for Cancer Therapy in the Era of Precision Medicine.
    K W To K; Cho WCS
    Curr Mol Pharmacol; 2022; 15(7):895-903. PubMed ID: 35156588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASGARD+: A New Modular Platform for Bacterial Antibiotic-Resistant Analysis.
    Montero-Vargas M; Saenz-Rojas A; Suárez-Esquivel M; Ramirez-Carvajal L
    Curr Protoc; 2023 Mar; 3(3):e680. PubMed ID: 36892262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
    Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
    BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Drug Repurposing-Based Precision Medicine Platform for Leukaemia Patient Treatment.
    Kenmogne VL; Nweke EE; Takundwa MM; Fru PN; Thimiri Govinda Raj DB
    Adv Exp Med Biol; 2023; 1410():115-126. PubMed ID: 36289161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Drugs for Skin Cancer.
    Khachigian LM
    Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
    Guo WF; Zhang SW; Feng YH; Liang J; Zeng T; Chen L
    Nucleic Acids Res; 2021 Apr; 49(7):e37. PubMed ID: 33434272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.